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ABSTRACT 
BACKGROUND 
Early introduction of peanut is an effective strategy to prevent peanut allergy in high-
risk infants; however, feasibility and effects on growth and nutritional intake are 
unknown. 
OBJECTIVE  
To evaluate the feasibility of introducing peanut in infancy and explore effects on 
growth and nutritional intake up to 60 months of age. 
METHODS 
In the Learning Early About Peanut Allergy (LEAP) trial, 640 atopic infants aged 4-11 
months were randomly assigned to consume (6g peanut protein/week) or avoid peanut 
until 60 months of age. Peanut consumption and early feeding practices were assessed 
by questionnaire. Dietary intake was evaluated with prospective food diaries. 
Anthropometric measurements were taken at all study visits.  
RESULTS 
Peanut was successfully introduced and consumed until 60 months with median peanut 
protein intake of 7.5g/week (IQR 6.0-9.0) in the consumption group compared to 0g in 
the avoidance group. Introduction of peanut in breastfeeding infants did not affect the 
duration of breastfeeding. There were no differences in anthropometric measurements 
or energy intakes between groups at any visits. Regular peanut consumption led to 
differences in dietary intakes. Consumers had higher intakes of fat and avoiders had 
higher carbohydrate intakes; differences were greatest at the upper quartiles of peanut 
consumption.  Protein intakes remained consistent between groups. 
CONCLUSIONS 
Introduction of peanut proved feasible in infants at high-risk of peanut allergy and did 
not affect the duration of breastfeeding nor impact negatively on growth or nutrition. 
Energy balance was achieved in both groups through variations in intakes from fat and 
carbohydrate while protein homeostasis was maintained.   
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Trial Registration ClinicalTrials.gov Identifier: NCT00329784. 
Funded by the National Institute of Allergy and Infectious Diseases and others.  
 
Abbreviations used: 
LEAP: Learning Early About Peanut Allergy 
FFQ: Food frequency questionnaire 
BMI: Body mass index 
DRV: Dietary reference value 
RNI: Reference nutrient intake 
LRNI: Lower reference nutrient intake  
%TE: Percentage of total energy  
ITT: Intent to treat 
IQR: Interquartile range  
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CAPSULE SUMMARY 
Our results demonstrate that the dietary intervention of regular peanut 
consumption from infancy as a strategy to prevent peanut allergy in high-risk 
infants is easily achieved and has no adverse effects on growth or nutrition. 
 
CLINICAL IMPLICATIONS STATEMENT 
Peanut consumption as a strategy to prevent peanut allergy, introduced in infancy 
and maintained to 5 years of age, is nutritionally safe even when consumption 
occurs at high levels.  
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INTRODUCTION 
We recently reported that early introduction of dietary peanut results in a marked 
reduction in the development of peanut allergy in high-risk infants.(1) The LEAP 
Study intervention disagrees with current WHO advice which recommends that infants 
should be exclusively breastfed for the first six months of life (no other food or 
water).(2) Similar to the dietary practices in the USA and Australia, the mean age of 
introduction of peanut-containing foods in the UK is 36 months and only around 8-
10% of infants eat peanut before one year of age.(3-5)   
 
Many professional allergy societies now recommend the LEAP Study intervention of 
early peanut introduction in infancy followed by ongoing regular consumption until 60 
months of age for the prevention of peanut allergy in high-risk infants.(6-8) This 
advice may in time be extended to encompass all children regardless of their risk of 
peanut allergy.  Whilst regular consumption of peanut from an early age appears to be 
an effective strategy for the prevention of peanut allergy in high-risk infants as well as 
in infants recruited from a general population, there could be unexpected consequences 
for growth and nutrition. (1,9) Anecdotally, no adverse health consequences have been 
associated with this practice in countries such as Israel, where peanut is regularly 
consumed by infants and young children.  Epidemiological studies describe beneficial 
health effects of regular nut consumption in children and adolescents including a lower 
body mass index (BMI), a higher healthy eating index and higher intakes of 
micronutrients.(10,11). Furthermore, there is a long tradition of using peanut as the 
mainstay of nutritional fortification programs in developing countries and even in the 
USA as part of the supplemental nutrition program for Women, Infants and 
Children.(12) Despite these dietary practices, intervention studies involving regular 
consumption of peanut or similar energy-dense foods in early childhood are lacking in 
the literature. 
 
The LEAP intervention recommended an intake of 6g peanut protein/week, equivalent 
to 3 teaspoons of peanut butter, based on the upper quartile of intake observed in 
infants in Israel (7.1g peanut protein/month).(3) It is unknown if this dietary 
recommendation is challenging to incorporate into the diet of the infant, or will lead to 
an imbalanced diet if eaten throughout childhood.  
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The objectives of this study were to evaluate the feasibility of introduction of peanut in 
infancy and the effects of regular ongoing consumption on growth, nutrition and diet of 
atopic infants enrolled onto a randomized controlled trial. Using data from the LEAP 
study, we compare infants randomized to consumption or avoidance of peanut during 
the first 5 years of life. 
METHODS 
Study Design 
This study represents a planned secondary analysis from the LEAP trial, a randomized, 
open-label, controlled trial comparing two strategies to prevent peanut allergy: 
consumption or avoidance of peanut in high-risk infants.  The primary outcomes and 
adverse event profile of this trial have been previously published.(1)  
Dietary intervention 
Infants aged 4 to <11 months with severe eczema and/or egg allergy were randomly 
assigned to consume or avoid peanut until 60 months of age. Participants randomized 
to peanut consumption (except those who were diagnosed with peanut allergy) were 
advised to eat at least 6g peanut protein/week distributed over three or more 
meals/week until age 60 months. The preferred peanut source was Bamba®, a snack-
food manufactured from peanut butter and puffed maize; this snack was suitable for 
infants and could also be easily softened to a smooth texture (with warm milk or water) 
and added to other infant foods, such as oatmeal. Smooth peanut butter (Sunpat® and 
Duerr’s® brands) was also provided by the study center; for safety, it was advised that 
this be loosened using warm (cooled, boiled) water prior to feeding infants.(13) Due to 
choking risk, it was also recommended that whole peanuts be avoided during early 
childhood.(13) Participants randomized to avoidance (and participants who were 
diagnosed with peanut allergy) were given detailed dietary advice on how to avoid 
exposure to peanut during study participation. They were advised that avoidance of 
products with peanut precautionary allergen labelling (where peanut was not a listed 
ingredient) was unnecessary unless diagnosed peanut allergic. Further details of the 
dietary advice provided are available in this article’s Online Repository (Figure E1 and 
Figure E2). 
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Peanut consumption monitoring 
Peanut consumption was monitored using a validated food frequency questionnaire 
(FFQ) at intervals as detailed in the schedule of events; adherence criteria are detailed 
elsewhere.(1,14) For subgroup analyses, peanut consumers were divided into quartiles 
based on average peanut consumption throughout the study as measured by FFQ. 
  
Growth and anthropometric measurements 
Anthropometric measurements were taken in duplicate and the mean value recorded by 
trained staff at each study visit. Length and height were measured to the nearest 0.1cm, 
using an infant measuring table (<2 years) or wall-mounted stadiometer (Harpenden, 
Crymych, UK) and weight to the nearest 0.1kg using an electronic scale (Marsden 
M700, Rotherham, UK). Waist circumference was measured to the nearest 0.1cm using 
an anthropometric measuring tape, triceps and subscapular skinfold thickness were 
measured to the nearest 0.1mm using skinfold calipers (Holtain, Crymych, UK). Body 
Mass Index (BMI) was calculated as weight/(height*height). Measurements were 
transformed into z-scores using the WHO Child Growth Standards.(15) 
Nutritional intake monitoring 
A 3-day food diary was completed prior to (or shortly after) each study visit. Detailed 
instructions were provided by study dietitians on how to complete the diary accurately. 
Food diaries were checked for completeness by a dietitian/dietetic assistant at the study 
visit and additional information or clarification sought where required including 
cooking methods and portion sizes. Those who had not completed some or all of the 
food diary were asked to return the diary by mail after the clinic visit. 
Foods and drinks were entered into Dietplan 6 (Forestfield Software Limited, UK) and 
analyzed to produce average daily energy, macronutrient and micronutrient intakes. 
Portion weights were assigned based on information from manufacturers, food 
packaging and/or estimated from standard food portion sizes all scaled down for age 
based on the details recorded in the food diary and portion size resources.(16-21)  
Nutrient intakes were compared with UK Dietary Reference Values (DRVs) by age 
and sex.(22-24) Further details on nutritional intake monitoring are available in this 
article’s online repository. 
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Types of foods consumed (average daily consumption in grams) over the duration of 
the study were compared between avoidance and consumption groups. All food codes 
entered into Dietplan were mapped to 61 food groups based on those reported 
elsewhere.(25) In addition, we separated out peanut-containing foods and specialist 
allergen-free products (e.g. wheat/gluten free cereals) which are more frequently eaten 
in this population compared to the general population.  
 
Statistical analysis  
All analyses were carried out in the intention to treat (ITT) population comparing the 
two randomized treatment groups cross-sectionally.  Anthropometry and skin fold 
measurements were compared using general linear models adjusted for treatment 
assignment and gender.  Percentage of total energy intakes were compared using 
equivariance t-tests. The proportion of participants with micronutrient intakes below 
lower reference nutrient intake (LRNI) levels were compared with Fisher’s exact tests. 
Micronutrient intakes, total protein intake, percent of total protein intake, and average 
daily consumption of different types of foods were compared using Wilcoxon tests. 
RESULTS 
Study participants 
The median age of participants at screening was 7.8 months (IQR, 6.3 to 9.1). The 
median duration of study participation was 4.4 years.  Additional baseline 
characteristics have been previously published.(1)  
 
Peanut consumption  
In the consumption group, average peanut intake exceeded the recommended study 
intake within the first month (median 7.5g/week; IQR 6.0-9.0g/week) post-
randomization, was sustained during the first six months of the intervention (median 
7.9g/week; IQR 6.6-9.2g/week) and on average increased throughout the study (Table 
I and Fig 1).  Median peanut intake in the avoidance group remained at 0g throughout 
the study.  
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The main sources of peanut changed over time (see Fig E3 in this article’s Online 
Repository): up until 21 months of age, participants consumed Bamba as their 
predominant source of peanut protein with peanut butter becoming the main source as 
participants got older. Other sources, including peanut-containing breakfast cereals and 
confectionary (e.g. cookies, chocolate or snack bars containing peanut) were minor 
sources of peanut protein. Crushed or ground whole peanuts were eaten by some 
participants from 12 months of age.  
 
Infant feeding pre- and post-randomization 
There were no differences in breastfeeding characteristics between treatment groups 
before or after randomization (Table I). The introduction of peanut did not result in a 
significantly shorter duration of breastfeeding in the peanut consumption group, even 
when adjusted for maternal highest level of education, gestational age at birth, and 
ethnicity. The mean duration of breastfeeding post-randomization was 4.7 months in 
the consumption group and 4.9 months in the avoidance group (p=0.56).  At the time 
of randomization, 290 participants had introduced infant formula in the consumption 
and 287 in the avoidance group. Solid foods were introduced at a mean age of 5 
months (range 2.0-7.0 months) in both groups. There were no differences in the age at 
which the following food allergens were introduced pre-randomization: dairy foods 
(excludes infant formula), egg, wheat, fish, soya, tree nuts.  
 
Growth, anthropometry and nutritional intakes 
Anthropometric measures and nutrient intakes were compared between randomized 
groups and in subgroup analyses which compared the highest quartile of peanut 
consumers with the peanut avoidance group.  
There were no differences in weight, height, BMI or other anthropometric 
measurements (waist circumference, subscapular and triceps skin fold thickness) 
between the consumption and avoidance groups at any time during the study (Fig 2). 
Even when comparing the highest quartile of peanut consumers to peanut avoiders, 
there were no differences in anthropometric measures (see Fig E4 in this article’s 
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Online Repository). There were also no differences in anthropometric measurements 
when compared to WHO child growth standards (see Table E1 in this article’s 
Online Repository).  
Food diary return rates 
There were no differences between randomized groups in the numbers of food diaries 
returned (see Table E2 in this article’s Online Repository). 
Energy and macronutrient intakes 
There were no differences in total energy intakes between randomized groups at any 
study time points and for the highest quartile of peanut consumers compared to peanut 
avoiders (see Fig E5 in this article’s Online Repository). 
 
The percentage of total energy (%TE) from carbohydrate was higher in the avoidance 
group compared to the consumption group at all post-randomization time points. 
Conversely, the %TE from fat was higher in the consumption group compared to the 
avoidance group at all post-randomization time points (Fig 3B). A cross-sectional 
comparison of macronutrient intakes across quartiles of peanut consumption found that 
small differences in contributions of carbohydrate and fat to %TE were accentuated in 
the upper quartiles of peanut consumption whereas %TE from protein remained 
consistent at all post-randomization time points for all quartiles of peanut consumption 
(Fig 3C) and in the avoidance group. When macronutrient subgroups were compared, 
%TE from starch was significantly higher at 21 and 30 months and %TE from sugars 
was significantly higher at 30 and 60 months in the avoidance group (see Fig E6a in 
this article’s Online Repository). There were no differences between randomized 
groups in %TE from saturated or polyunsaturated fatty acids at any time point. Intakes 
of monounsaturated fatty acids were significantly higher in the consumption group at 
60 months. (see Fig E6b in this article’s Online Repository).  
When compared with UK DRVs, mean protein intakes in both groups were well above 
the RNI whilst fat intakes met DRVs at all study visits.(22) Mean carbohydrate intakes 
fall just above the recommended 50%TE for children aged 2 years and older in the 
avoidance group at all post-randomization time points. In the consumption group 
carbohydrate intakes fall just below the DRV at 12 and 21 months, are at the DRV at 
30 months and just above at 60 months.(23)  
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Sodium, calcium, iron, zinc, vitamin D 
As peanut-containing foods often have added sodium, we assessed this intake between 
peanut avoiders and consumers. Sodium intake was elevated for all participants (144-
244% above UK recommendations); this intake was not significantly different between 
randomized groups or in the highest peanut consumers compared to peanut avoiders. 
(see Tables E3a, E3b and E3c in this article’s Online Repository Table).(24,26)  
 
Calcium, iron, zinc and vitamin D intakes (expressed as a percentage of the RNI) were 
compared as intakes of these micronutrients are often compromised in children with 
food allergies.(27-29) There were no differences in intakes for calcium (except at 12 
months), iron or zinc. There were no differences between groups in intakes of vitamin 
D; however, intake decreased over time. There is no RNI for vitamin D above 3 years 
of age so intake as a percentage of RNI at 60 months could not be calculated (Table 
II).  
 
There were no differences in the proportion of participants with intakes of iron, 
calcium or zinc below the lower reference nutrient intake (LRNI) (Table III). A higher 
than expected proportion of participants in both randomized groups had intakes of iron 
and zinc below the LRNI; at baseline, 12, 21 and 30 months of age for iron and at all 
time points for zinc (apart from peanut avoidance group at 21 months).  
 
Foods consumed 
Participants randomized to consumption ate significantly less of the following food 
groups: ‘crisps/chips and savory snacks’, ‘high fiber bread’, ‘fruit juices and 
smoothies’, ‘spreads’ (e.g. jam, yeast extract), ‘low energy dense sauces’ (includes 
gravy, ketchup, mustard, tomato-based pasta sauce), ‘sunflower/other oils and fat 
spreads’ and ‘dairy free spreads’ (see Table E4 and Table E5 in this article’s Online 
Repository).  
To see whether the consumption of peanut, a source of vegetable protein, led to a 
reduced intake of protein from other sources in order to maintain overall protein 
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homeostasis, we compared the sources of protein (expressed as total intake in grams 
and percent of total protein intake) in the avoidance and consumption groups. There 
were no differences between randomized groups in protein intake from different 
sources at any post randomization time point (except for ‘other’ sources at 12 months) 
(Table IV). However, when we compared the highest quartile of peanut consumers to 
the avoiders, we found significantly higher intakes of vegetable protein and lower 
intakes of animal protein expressed as a percent of total grams at 21, 30, and 60 
months. (Table V).  
DISCUSSION 
The LEAP Study successfully introduced peanut to the diet of infants randomized to 
peanut consumption. The recommended intake was achieved in the first month of the 
study and maintained throughout, confirming the ease with which peanut can be 
introduced to the infant diet. Whilst Bamba and peanut butter accounted for the 
majority of peanut intake during the early years of the trial, peanut butter consumption 
increased after 21 months, showing that the intervention can be undertaken using a 
variety of peanut products. Despite eating different peanut-containing foods, even 
whole peanuts from the age of 12 months, no episodes of participant choking or 
aspiration were reported. However, clinicians should still emphasize that whole 
peanuts and chunks of peanut butter are a choking hazard in young children and should 
not be consumed before 5 years of age.(6-8,13)  
The timing of introduction of other allergenic foods was equivalent between groups 
prior to randomization. A high proportion of LEAP infants were breastfeeding at the 
time of introducing peanut and, reassuringly, peanut consumption did not affect the 
duration of breastfeeding. Whilst the study intervention does not comply with WHO 
guidelines on exclusive breastfeeding, it did not negatively impact breastfeeding itself. 
This is important due to concerns that introduction of solid foods before 6 months of 
age will reduce breastfeeding duration.(30) Our finding is supported by other 
studies.(31,32)  We know that in the UK, 30% of infants have already introduced solid 
foods by 4 months and 75% by 5 months of age i.e. do not comply with WHO 
guidelines on exclusive breastfeeding.(5) In addition, for some infants the introduction 
of allergenic foods between 4-6 months may be important for allergy prevention.(33-
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35) Our results show that in high-risk infants, early consumption of peanut from 4 
months of age is safe and effective for allergy prevention.  
Peanut consumption did not lead to differences in weight, height, BMI, or other 
anthropometric measurements even amongst the highest quartile of peanut consumers.  
Macronutrient intakes in both groups were in line with UK recommendations apart 
from carbohydrate which fell close to the recommended intake (DRV for 2-5 year olds 
defined in 2015). When compared to US dietary reference intakes, which have wider 
ranges than the UK, both groups meet acceptable macronutrient distribution ranges for 
protein, fat and carbohydrate at all study visits.(36) Sodium intakes were above UK 
recommended maximum intakes in both groups but below US recommended 
maximum intakes.(26) Although iron and zinc intakes were low for some participants, 
similar proportions of young children with intakes below the LRNI have been reported 
by the recent UK national dietary survey.(37) 
 
Nutritional priorities of maintenance of energy and protein homeostasis are achieved in 
different ways in peanut consumers compared to avoiders. Peanut consumption led to a 
higher fat intake and a lower carbohydrate intake compared to avoidance while energy 
balance was maintained in both groups. These differences in fat and carbohydrate 
intakes were accentuated in the highest quartile of peanut consumers while protein 
intake stayed constant across quartiles of peanut consumption and in the avoidance 
group. We believe this shows evidence of protein regulation occurring in children from 
an early age. The addition of peanut-containing foods did not affect %TE intake from 
protein because intake from other sources (animal protein sources) was decreased to 
maintain protein homeostasis; energy balance was maintained by adjusting non-protein 
energy intakes (i.e. fat and carbohydrate). Similarly, an experimental study found that 
adult participants restored protein homeostasis through increased selection of high 
protein foods such that they had a 13% higher protein intake after a 14 day low protein 
diet compared to after a high protein diet. (38)    
 
Peanut consumers made different food choices to peanut avoiders. They had a lower 
intake of fat spreads and oils than the avoidance group; however, their overall intake of 
fat as %TE was higher. This likely reflects their using peanut butter in place of fat 
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spreads. Peanut butter tends to be spread more generously and also parents/caregivers 
may have given larger portions to ensure the participant achieved their target peanut 
protein intake (a generous teaspoon or 8g of smooth peanut butter contains 
approximately 2g of peanut protein).   
 
Peanut consumers also ate significantly less crisps/chips and savory snacks, high fiber 
bread, fruit juices and smoothies, spreads (e.g. jam, yeast extract), low energy dense 
sauces (includes gravy, ketchup, mustard, tomato-based pasta sauce), than peanut 
avoiders.  Many of these foods have a high carbohydrate content supporting the lower 
carbohydrate intakes found in the consumption group. We are unable to say whether 
reduced consumption of these foods is due to development of different taste 
preferences through repeat peanut exposure from infancy (increased liking for fruit and 
vegetables has been observed in children with repeat exposure from infancy), or 
whether having a predetermined snack means that other popular snack choices are not 
selected. Alternatively, regulatory processes may influence self-selection of specific 
foods to avoid imbalances in protein and total energy intake which we observe occurs 
with intakes of different protein sources in the highest peanut consumers.(39-41)  
                                                                                                            
The nutritional intake data is subject to the limitations of estimated food diaries which 
are well described including the challenges of accurately quantifying portion sizes, 
over-, under- and mis-reporting of dietary intakes by participants and missing 
nutritional data in UK food tables.(42)  Nonetheless this method provides a level of 
detail about dietary intake that cannot be obtained by other methods such as FFQs.(43) 
We have also previously described the limitations associated with the use of FFQ's for 
the accurate determination of peanut intake.(14) The favorable LEAP nutritional 
results may not be generalizable to children in the general population who have less 
dietetic support with peanut consumption, less frequent monitoring of peanut intakes 
and of growth and nutritional intakes during treatment.  
Our study has several strengths. The high study retention over 5 years (98%), high 
adherence to the randomized intervention (92%), regular collection of peanut 
consumption and avoidance information by FFQ (median number of 80 phone contacts 
per participant)  ensure robust data were gathered. This is enhanced by the high return 
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rate of food diaries (83% returned ≥4 food diaries) with collection on 5 occasions from 
infancy to 60 months alongside detailed growth data. In addition, we show that infants 
and young children not only maintain energy balance in response to dietary 
manipulation but also regulate their protein intakes.  
In conclusion, this is the first randomized trial to introduce peanut in infancy and 
demonstrates that the intervention is easily achieved and has no adverse dietary 
sequelae. In addition to a reduction in peanut allergy at 60 months of age, peanut 
consumption did not negatively impact growth in childhood even at the highest quartile 
of consumption. These findings are reassuring in the context of new consensus 
communications to feed peanut early to high-risk, atopic infants.(6-8)  Interestingly, 
we found that despite peanut consumers making different food choices to peanut 
avoiders, both achieved nutritional priorities of energy and protein homeostasis. This 
occurs through a trade-off between carbohydrate and fat contributions to energy intake. 
 
Implications for clinicians:  
Peanut consumption as a strategy to prevent peanut allergy, introduced in infancy is 
nutritionally safe even when consumption occurs at high levels. However, 
parents/caregivers must be reminded that whole peanuts should not be given to 
children below 5 years due to choking risk. 
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FIGURE LEGENDS 
 
Table I. Infant feeding characteristics  
[1] P-value is from a Chi-Square test comparing the percentage of subjects in the 
Avoidance to the Consumption group. [2] P-value is from a Wilcoxon Rank Sum Test 
comparing the distributions in the Avoidance to the Consumption group. [3] Dairy 
refers to solid foods (e.g. yogurt or cheese). [4] Source of Peanut Consumption comes 
from the Food Frequency Questionnaire (FFQ). 
 
Fig 1. Average peanut consumption over time (grams peanut protein per week)  
Peanut consumption summarized throughout the study from FFQs completed at 
baseline and between study visits. Median weekly consumption during the first 2 years 
of life (per-protocol adherence) has been previously published.(1) Grey dots denote 
subjects randomized to the avoidance group.  Green dots denote subjects randomized to 
the consumption group.   Red circles denote participants who were peanut allergic at 60 
months.  
Fig 2. Growth & anthropometry in avoidance and consumption groups (ITT sample)  
Measures are weight, height, body mass index (BMI), subscapular skinfold thickness, 
triceps skinfold thickness, waist circumference. The bottom panel displays the 
difference in means (consumption – avoidance) and 95% confidence intervals between 
the two randomized groups resulting from a model adjusted for randomization 
assignment and gender. 
Fig 3. Macronutrient intakes in avoidance & consumption groups as percentage of 
total energy intake (ITT sample) and differences in mean macronutrient intakes by 
quartile of peanut consumption  
Panel A displays all data for both randomized groups. Panel B displays the 
difference in means (consumption – avoidance) and 95% confidence intervals 
between the two randomized groups resulting from equivariance T-tests. Panel C 
displays the difference in means (consumption – avoidance) and 95% confidence 
intervals between the avoidance group and each quartile of peanut consumption 
resulting from equivariance T-tests.  
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Table II. Average daily intake of select micronutrients as percentage of the reference 
nutrient intake (RNI1). 
P values are based on Wilcoxon tests comparing all avoiders to all consumers 
within each visit. Summary Statistics are displayed as Mean (SD), Median, and 
Interquartile Range respectively. 
1. The RNI is the amount of a nutrient sufficient for 97% of the population. 
 
Table III. Proportion of participants with average daily intakes of select 
micronutrients below the lower reference nutrient intake (LRNI1). 
Percentages are calculated from the total number of participants in each 
treatment group with available data within each visit.  P-values are based on 
Fisher’s Exact tests. 
1. The LRNI is the amount that is adequate for only around 2.5% of the 
population. 
Table IV. Comparison of sources of protein (animal or vegetable) in avoidance and 
consumption groups (total grams consumed and percent of total protein intake). 
 
Animal sources included the following food groups: milk/milk products, infant 
formula, eggs/egg dishes, meat/meat products, fish/fish products 
 
Vegetable sources included: cereal/cereal products, milk substitutes, meat 
alternatives, vegetables/potatoes, nuts/seeds, savory snacks, fruit  
 
Other sources included: fat spreads/oils, sugar and confectionery, non-
alcoholic beverages, miscellaneous 
P-values are based on Wilcoxon tests comparing all avoiders to all consumers within 
each visit. 
 
Table V. Comparison of sources of protein (animal or vegetable) for all avoiders 
compared to the highest quartile of peanut consumption (total grams consumed and 
percent of total protein intake). 
P-values are based on Wilcoxon tests comparing all avoiders to the highest quartile of 
peanut consumers within each visit. 
 
